This content is machine translated Cardiovascular risk and obesity Pathomechanisms, secondary prevention and treatment options Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right...… CME-Test
View Post 12 min This content is machine translated Liver steatosis with metabolic dysfunction New nomenclature for non-alcoholic fatty liver disease The term “non-alcoholic steatohepatitis” (NASH) was originally used to describe liver damage characterized by lobular inflammation, steatosis and ballooning of hepatocytes. In addition, a large proportion of patients were described...… CME-Test
View Post 5 min This content is machine translated Obesity in childhood and adolescence Multifactorial disease with multiple implications The prevalence of obesity in children and adolescents has risen in recent decades. The categorization of BMI is age- and gender-specific. Studies show that BMI status at a young age...…
View Post 3 min This content is machine translated Early breast cancer Overweight and obesity worsen the prognosis A database analysis by the Early Breast Cancer Trials Collaborative Group (EBCTCG ) showed that obesity in early-stage breast cancer was only associated with increased breast cancer mortality in pre-...…
View Post 3 min This content is machine translated Post-bariatric hypoglycemia (PBH) The diagnosis is “somehow difficult” As the prevalence of obesity continues to rise worldwide, bariatric surgery remains an extremely effective measure in the treatment of severe cases. The surgical procedure results in significant weight loss,...…
View Post 19 min This content is machine translated Cardiovascular risk and obesity Pathomechanisms, secondary prevention and treatment options Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right...… CME-Test
View Post 2 min This content is machine translated Tirzepatide after the menopause stage Significant reduction in KG and waist circumference In the SURMOUNT program (SM), treatment with tirzepatide led to a significant and clinically meaningful reduction in body weight (BW) in overweight and obese subjects. In a post-hoc analysis, the...…
View Post 19 min This content is machine translated Cardiovascular risk and obesity Pathomechanisms, secondary prevention and treatment options Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right...… CME-Test
View Post 4 min This content is machine translated Study report: Obesity New findings on the effects of incretin analogs A study by Aronne et al. investigated the effects of the dual GLP1/GIP receptor agonist (RA) tirzepatide in obese patients when it is administered over a longer period of therapy...…
View Post 10 min This content is machine translated Obesity Possibilities of nutritional therapy The prevalence of people with overweight and obesity in Europe is almost 60%, and the World Health Organization (WHO) estimates that obesity is (partly) responsible for around 1.2 million deaths… CME-Test
View Post 10 min This content is machine translated Obesity Possibilities of nutritional therapy The prevalence of people with overweight and obesity in Europe is almost 60%, and the World Health Organization (WHO) estimates that obesity is (partly) responsible for around 1.2 million deaths… CME-Test
